We are live on ! Find out more
RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.7B
1-Year Est. Return 93.03%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+93.03%
3 Year Est. Return
+228.43%
5 Year Est. Return
+368.14%
10 Year Est. Return
+4,607.77%
AUM
$558M
AUM Growth
+$124M
Cap. Flow
+$99.9M
Cap. Flow %
17.91%
Top 10 Hldgs %
37.3%
Holding
93
New
18
Increased
51
Reduced
4
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$27.2M
2
MDT icon
Medtronic
MDT
+$25.2M
3
CI icon
Cigna
CI
+$8.15M
4
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$7.58M
5
AET
Aetna Inc
AET
+$7M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$24.6M
2
UNH icon
UnitedHealth
UNH
+$14.8M
3
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$11.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$9.64M
5
ABBV icon
AbbVie
ABBV
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 75.87%
2 Industrials 2.28%
3 Financials 1.34%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETRM
76
DELISTED
EnteroMedics Inc.
ETRM
$1.33M 0.24%
810
+191
+31% +$357K
EXEL icon
77
Exelixis
EXEL
$13.4B
$678K 0.12%
200,000
-49,000
-20% -$169K
DARE icon
78
Dare Bioscience
DARE
$21M
$497K 0.09%
+714
New +$551K
BMY icon
79
Bristol-Myers Squibb
BMY
$132B
– –
-185,500
Closed -$9.64M
JAZZ icon
80
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-19,750
Closed -$2.74M
JNJ icon
81
Johnson & Johnson
JNJ
$625B
– –
-250,000
Closed -$24.6M
MD icon
82
Pediatrix Medical
MD
$2.2B
– –
-32,500
Closed -$2.01M
PBYI icon
83
Puma Biotechnology
PBYI
$454M
– –
-3,728
Closed -$388K
UHS icon
84
Universal Health Services
UHS
$10.5B
– –
-45,000
Closed -$3.69M
UNH icon
85
UnitedHealth
UNH
$370B
– –
-181,000
Closed -$14.8M
VTRS icon
86
Viatris
VTRS
$18.9B
– –
-53,000
Closed -$2.59M
XLV icon
87
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
– –
-200,000
Closed -$11.7M
CNCE
88
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-59,553
Closed -$801K
CERN
89
DELISTED
Cerner Corp
CERN
– –
-42,000
Closed -$2.36M
CSLT
90
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
– –
-100,000
Closed -$2.12M
DRNA
91
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-105,000
Closed -$2.97M
GWPH
92
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-17,750
Closed -$1.05M
RCPT
93
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-50,000
Closed -$2.1M
1 2 3
4

Similar funds

ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
II
Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return

Rock Springs Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Rock Springs Capital Management held 93 positions worth $558M, up 29% from $434M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Rock Springs Capital Management deployed $99.9M of net new capital in Q2 2014, opening 18 new positions and adding to 51 existing holdings. Its largest new stake was Merck: 497,800 shares worth $27.5M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 79% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $4.46M trimmed.

  • Rock Springs Capital Management's largest Q2 2014 buy was Merck: 497,800 shares worth $27.5M.
  • Rock Springs Capital Management added most to Alexion Pharmaceuticals in Q2 2014, an estimated $5.88M increase.
  • Rock Springs Capital Management's biggest Q2 2014 reduction was AbbVie, cutting an estimated $4.46M.
  • Rock Springs Capital Management fully exited Johnson & Johnson in Q2 2014, selling an estimated $24.6M.
  • Rock Springs Capital Management's ten largest holdings make up 37% of its $558M portfolio in Q2 2014.
  • Rock Springs Capital Management opened 18 new positions and closed 15 in Q2 2014.
  • Rock Springs Capital Management's portfolio value rose 29% quarter-over-quarter to $558M.

Based on Rock Springs Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.